Lumosa Therapeutics partners with Camargo Pharmaceutical Services for the development of its analgesic in the US

Taipei, Taiwan-based Lumosa Therapeutics Co., Ltd., a company focused on developing treatments for neurological and inflammatory disease, announced recently that it had engaged Cincinnati-headquartered Camargo Pharmaceutical Services for regulatory consulting and strategic development services for LT1001 (Naldebain®, dinalbuphine sebacate IM injection) in the US.

Read more

Aslan Pharmaceuticals announces collaboration with Taiwan’s leading genomic research institute

Singapore-headquartered ASLAN Pharmaceuticals (ASLAN, 6497.TT), a biotech company focused on the development of immunotherapies and targeted treatments for Asia prevalent cancer types, recently announced the signing of a research collaboration agreement with Academia Sinica’s Genomic Research Centre, one of Taiwan’s eminent research institutions.

Read more

“BioTaiwan’s growth is a reflection of the success of Taiwan biotech as a whole in recent years”

In Taiwan, biotech is finally booming, and new companies, service providers and manufacturing facilities are emerging to fill rapidly growing industry needs. BioSpectrum Asia recently spoke to Dr. Apo Huang, Secretary General, BioTaiwan on the current growth in the Taiwanese biotech sector.

Read more